Dulera 100-5mcg Oral Inhaler 120inh

Manufacturer ORGANON Active Ingredient Mometasone and Formoterol(moe MET a sone & for MOH te rol) Pronunciation moe MET a sone & for MOH te rol
It is used to treat asthma.Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
🏷️
Drug Class
Antiasthmatic, Bronchodilator
🧬
Pharmacologic Class
Inhaled Corticosteroid (ICS), Long-Acting Beta2-Adrenergic Agonist (LABA)
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Jun 2010
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Dulera is an inhaler that contains two medicines: a corticosteroid (mometasone) to reduce inflammation in your lungs and a long-acting bronchodilator (formoterol) to help keep your airways open. It's used twice a day to help control asthma or COPD symptoms and prevent flare-ups, but it's not for sudden breathing problems.
πŸ“‹

How to Use This Medicine

Proper Use of Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for inhalation only.

Preparing Your Inhaler

Before using your inhaler for the first time or if you haven't used it in more than 5 days, prime it by spraying 4 times into the air, away from your face and eyes. Shake the inhaler well before each use.

Using Your Inhaler

Continue to use this medication as directed by your doctor or healthcare provider, even if you're feeling well. To avoid getting the medication in your eyes, keep the inhaler away from your face. If the medication does get in your eyes, rinse them with plenty of water. If eye irritation persists, consult your doctor.

After each use, shake the inhaler well and rinse your mouth with water. Do not swallow the rinse water; spit it out instead. Replace the cap on the inhaler after each use.

Tracking Your Doses

Some inhalers have a dose counter to help you keep track of the number of doses left. If your inhaler has a dose counter, discard it when the counter reaches "0".

Important Safety Precautions

Do not use your inhaler near an open flame or while smoking, as it may cause the canister to burst. Use a new inhaler with each refill, and only use the device provided with this medication. Do not use any other devices or attempt to take the device apart or wash it in water. Clean the mouthpiece with a dry wipe at least every 7 days.

If you're using multiple inhaled medications, consult your doctor about which one to use first.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, away from bathrooms. For the 60-puff inhaler, store it with the mouthpiece down or sideways. The storage position doesn't matter for the 120-puff inhaler.

Missing a Dose

If you miss a dose, skip it and return to your regular schedule. Do not take two doses at the same time or extra doses.
πŸ’‘

Lifestyle & Tips

  • Use Dulera regularly, twice a day, every day, even if you feel well. Do not stop using it without talking to your doctor.
  • Do NOT use Dulera for sudden breathing problems. Always carry a fast-acting rescue inhaler (like albuterol) for acute symptoms.
  • Rinse your mouth with water and spit it out after each use of Dulera to help prevent a fungal infection (thrush) in your mouth and throat.
  • Learn and practice proper inhaler technique as demonstrated by your healthcare provider.
  • Keep track of your asthma symptoms and peak flow readings if advised by your doctor.
  • Do not exceed the prescribed dose.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 2 inhalations twice daily (morning and evening)

Condition-Specific Dosing:

asthmaMaintenance: 2 inhalations of Dulera 100 mcg/5 mcg twice daily
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for children under 12 years of age
Adolescent: For patients 12 years of age and older: 2 inhalations of Dulera 100 mcg/5 mcg twice daily
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment recommended
Moderate: No dosage adjustment recommended
Severe: No dosage adjustment recommended
Dialysis: No specific recommendations; systemic exposure is low

Hepatic Impairment:

Mild: No dosage adjustment recommended
Moderate: Use with caution; increased systemic exposure to mometasone furoate may occur
Severe: Use with caution; increased systemic exposure to mometasone furoate may occur

Pharmacology

πŸ”¬

Mechanism of Action

Mometasone furoate is a corticosteroid that exhibits potent anti-inflammatory activity. It inhibits multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, cytokines) involved in allergic and non-allergic-mediated inflammation. Formoterol fumarate is a long-acting selective beta2-adrenergic agonist (LABA) that stimulates intracellular adenyl cyclase, an enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased cAMP levels cause relaxation of bronchial smooth muscle and inhibition of mediator release from mast cells in the airway.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Mometasone: Low systemic bioavailability (<1% for inhaled dose); Formoterol: Rapidly absorbed, absolute bioavailability not determined but systemic exposure is low.
Tmax: Mometasone: ~1-2 hours; Formoterol: ~10-20 minutes
FoodEffect: Not applicable for inhaled medication

Distribution:

Vd: Mometasone: ~152 L; Formoterol: ~2.4 L/kg
ProteinBinding: Mometasone: ~98-99%; Formoterol: ~61-64%
CnssPenetration: Limited

Elimination:

HalfLife: Mometasone: ~5.8 hours; Formoterol: ~10 hours (terminal)
Clearance: Mometasone: ~12.1 L/hr; Formoterol: ~150 L/hr
ExcretionRoute: Mometasone: Primarily feces; Formoterol: Primarily urine (60%) and feces (33%)
Unchanged: Mometasone: Very little; Formoterol: ~6-10% in urine
⏱️

Pharmacodynamics

OnsetOfAction: Formoterol: Within minutes (1-3 minutes); Mometasone: Therapeutic effects develop over days to weeks
PeakEffect: Formoterol: 1-3 hours; Mometasone: Peak anti-inflammatory effects may take several weeks of regular use
DurationOfAction: Formoterol: Up to 12 hours; Mometasone: Sustained with regular twice-daily dosing

Safety & Warnings

⚠️

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as formoterol, increase the risk of asthma-related death. Data from a large, randomized, placebo-controlled clinical trial in asthma showed that LABAs increase the risk of asthma-related death. This finding is considered a class effect of LABAs. The safety and effectiveness of Dulera in patients with asthma have not been established in children less than 12 years of age. Dulera is not indicated for the relief of acute bronchospasm.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal.
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath.
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat.
Signs of a weak adrenal gland: severe nausea or vomiting, extreme dizziness or fainting, muscle weakness, fatigue, mood changes, decreased appetite, or weight loss.
Signs of high or low blood pressure: severe headache or dizziness, fainting, or changes in vision.
Chest pain or pressure.
Rapid or abnormal heartbeat.
Feeling anxious or jittery.
Shakiness.
Seizures.
Difficulty sleeping.
Severe nausea or vomiting.
Redness or white patches in the mouth or throat.
Changes in vision, eye pain, or severe eye irritation.
Feeling tired or weak.
Flushing.

Important Respiratory Warning

This medication can cause severe breathing problems, which may be life-threatening, shortly after taking a dose. If you experience difficulty breathing, worsening breathing, wheezing, or coughing after using this medication, use a rescue inhaler and seek immediate medical attention.

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or persist, contact your doctor:

Headache.
Nose or throat irritation.
Common cold symptoms.
* Flu-like symptoms.

This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening asthma symptoms (e.g., increased wheezing, shortness of breath, cough, chest tightness)
  • Increased need for your rescue inhaler
  • Signs of infection in your mouth or throat (white patches)
  • Signs of a serious allergic reaction (rash, hives, swelling of face/mouth/tongue, difficulty breathing)
  • Heart problems (chest pain, fast or irregular heartbeat, palpitations)
  • Vision changes (blurred vision, eye pain, glaucoma, cataracts)
  • Signs of adrenal problems (unusual tiredness, weakness, nausea, vomiting, dizziness, fainting)
  • Signs of high blood sugar (increased thirst, increased urination, hunger, confusion)
  • Muscle cramps or weakness (low potassium)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking another medication similar to this one. If you are unsure, consult your doctor or pharmacist to determine if there are any potential interactions.

This list is not exhaustive, and it is crucial to disclose all of your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you may have. Your doctor and pharmacist need this information to ensure that it is safe for you to take this medication in conjunction with your other medications and health conditions.

To avoid any potential interactions or complications, do not start, stop, or change the dosage of any medication without first consulting your doctor. It is your responsibility to verify that it is safe to take this medication with all of your other medications and health problems.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. If you have diabetes (high blood sugar), consult with your doctor, as this drug may increase your blood sugar levels.

You may not experience the full effects of this medication for a few weeks. If your breathing problems worsen, your rescue inhaler becomes less effective, or you need to use it more frequently, contact your doctor immediately.

Do not exceed the recommended dose or frequency of this medication, as overdoses of this type of drug have been fatal. Consult with your doctor if you have any concerns.

If you have been taking this medication for an extended period, consult with your doctor before stopping, as you may need to gradually taper off the medication to avoid potential side effects.

When transitioning from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects, including weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar. If you experience any of these symptoms, contact your doctor immediately.

In the event of a severe injury, surgery, or infection, you may require additional doses of oral steroids to help your body cope with the stress. Carry a warning card indicating that you may need extra steroids in such situations.

Long-term use of this medication may increase your risk of developing cataracts or glaucoma. Consult with your doctor and schedule regular eye exams as recommended.

Prolonged use of this medication may also lead to osteoporosis (weak bones). Discuss your risk factors with your doctor and ask about any concerns you may have.

You may be more susceptible to infections while taking this medication. To minimize your risk, wash your hands frequently and avoid close contact with people who have infections, colds, or flu.

If you have not had chickenpox or measles before, avoid exposure to these illnesses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed to chickenpox or measles, consult with your doctor immediately.

In some cases, this medication may affect growth in children and teenagers. Regular growth checks may be necessary, so consult with your doctor.

If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the potential benefits and risks of this medication with your doctor to ensure the best possible outcome for you and your baby.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Formoterol overdose: Tachycardia, palpitations, tremor, headache, nausea, dizziness, hypokalemia, hyperglycemia, metabolic acidosis, angina, hypertension, hypotension, arrhythmias
  • Mometasone overdose: Acute overdose is unlikely due to low systemic absorption. Chronic overdose may lead to signs of hypercorticism (Cushing's syndrome) or adrenal suppression.

What to Do:

Seek immediate medical attention or call a poison control center (1-800-222-1222). Treatment is supportive and symptomatic. Consider cardioselective beta-blockers for formoterol overdose, but use with extreme caution in patients with a history of bronchospasm.

Drug Interactions

🚫

Contraindicated Interactions

  • Other long-acting beta2-adrenergic agonists (LABAs) (e.g., salmeterol, arformoterol, indacaterol, olodaterol)
  • Non-selective beta-blockers (e.g., propranolol, carvedilol) in patients with asthma
πŸ”΄

Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, clarithromycin, itraconazole, cobicistat-containing products) - may increase systemic exposure to mometasone
  • QT-prolonging drugs (e.g., quinidine, disopyramide, sotalol, phenothiazines, tricyclic antidepressants, macrolide antibiotics) - may potentiate formoterol's effect on the cardiovascular system
  • Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants (TCAs) - within 2 weeks of use, may potentiate formoterol's effect on the cardiovascular system
🟑

Moderate Interactions

  • Diuretics (e.g., loop or thiazide diuretics) - may potentiate hypokalemia and/or ECG changes associated with beta-agonists
  • Other sympathomimetic agents - may potentiate adverse cardiovascular effects
  • Xanthine derivatives (e.g., theophylline) - may potentiate hypokalemia
🟒

Minor Interactions

  • Not specifically identified for minor interactions with Dulera

Monitoring

πŸ”¬

Baseline Monitoring

Pulmonary Function Tests (FEV1)

Rationale: To establish baseline lung function and assess disease severity

Timing: Prior to initiation of therapy

Asthma Control Assessment

Rationale: To establish baseline symptom burden and quality of life

Timing: Prior to initiation of therapy

πŸ“Š

Routine Monitoring

Asthma Symptoms and Rescue Inhaler Use

Frequency: Daily (patient self-monitoring)

Target: Minimal symptoms, infrequent rescue inhaler use

Action Threshold: Worsening symptoms, increased rescue inhaler use, nocturnal awakenings, decreased peak flow readings

Pulmonary Function Tests (FEV1)

Frequency: Periodically (e.g., every 6-12 months or as clinically indicated)

Target: Maintenance or improvement from baseline

Action Threshold: Significant decline in FEV1

Oral Cavity Inspection

Frequency: Regularly (e.g., at each clinic visit)

Target: Absence of white patches

Action Threshold: Presence of oral candidiasis (thrush)

Growth (Pediatric Patients)

Frequency: Regularly (e.g., every 3-6 months)

Target: Normal growth velocity for age

Action Threshold: Growth retardation

Signs of Systemic Corticosteroid Effects

Frequency: Periodically (e.g., adrenal suppression, bone mineral density, cataracts/glaucoma)

Target: Absence of signs/symptoms

Action Threshold: Development of Cushingoid features, adrenal insufficiency, bone fractures, vision changes

Serum Potassium and Blood Glucose

Frequency: Periodically, especially in patients with predisposing conditions or on concomitant medications

Target: Normal ranges

Action Threshold: Hypokalemia, hyperglycemia

πŸ‘οΈ

Symptom Monitoring

  • Worsening asthma symptoms (e.g., increased wheezing, shortness of breath, cough)
  • Increased need for rescue inhaler (e.g., albuterol)
  • Decreased peak expiratory flow (PEF) readings
  • Signs of oral candidiasis (white patches in mouth or throat)
  • Signs of systemic corticosteroid effects (e.g., easy bruising, moon face, weight gain, fatigue, vision changes)
  • Palpitations, tremor, chest pain (potential beta-agonist effects)

Special Patient Groups

🀰

Pregnancy

Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. There are no adequate and well-controlled studies of Dulera in pregnant women. Animal studies have shown teratogenic effects with mometasone and formoterol.

Trimester-Specific Risks:

First Trimester: Potential for teratogenic effects observed in animal studies with high doses of individual components.
Second Trimester: Risk of fetal growth restriction with prolonged high-dose corticosteroid use.
Third Trimester: Risk of neonatal adrenal insufficiency with prolonged high-dose corticosteroid use. Formoterol may inhibit labor.
🀱

Lactation

Caution should be exercised when Dulera is administered to a nursing woman. It is not known whether mometasone furoate or formoterol fumarate are excreted in human milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Dulera and any potential adverse effects on the breastfed infant from Dulera or from the underlying maternal condition.

Infant Risk: Low risk for mometasone due to low systemic absorption; low risk for formoterol. Monitor infant for signs of systemic corticosteroid effects or beta-agonist effects (e.g., irritability, tremor).
πŸ‘Ά

Pediatric Use

Safety and effectiveness have not been established in children younger than 12 years of age. Monitor growth velocity in pediatric patients receiving corticosteroids, as they may cause a reduction in growth velocity.

πŸ‘΄

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Monitor for cardiovascular effects due to formoterol and potential for increased susceptibility to systemic corticosteroid effects.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Dulera is a maintenance medication and should not be used for acute asthma attacks or sudden shortness of breath. Patients should always have a rescue inhaler available.
  • Proper inhaler technique is crucial for effective drug delivery. Educate patients on how to use the inhaler correctly and to rinse their mouth after each use to prevent oral candidiasis.
  • Due to the LABA component, Dulera should only be used in asthma patients who are not adequately controlled on an inhaled corticosteroid alone or whose disease severity clearly warrants initiation of treatment with both an ICS and a LABA.
  • Monitor patients for signs of systemic corticosteroid effects, especially with prolonged use or higher doses, including adrenal suppression, bone mineral density changes, and ocular effects (glaucoma, cataracts).
  • Patients should be advised to report any worsening of asthma symptoms, increased rescue inhaler use, or signs of infection immediately to their healthcare provider.
πŸ”„

Alternative Therapies

  • Inhaled Corticosteroid (ICS) monotherapy (e.g., mometasone, fluticasone, budesonide)
  • Long-Acting Muscarinic Antagonists (LAMAs) (e.g., tiotropium, umeclidinium)
  • Leukotriene Receptor Antagonists (LTRAs) (e.g., montelukast)
  • Oral corticosteroids (for severe exacerbations)
  • Biologic therapies (e.g., omalizumab, mepolizumab, benralizumab, dupilumab) for severe asthma
πŸ’°

Cost & Coverage

Average Cost: $300 - $450 per inhaler (120 actuations)
Insurance Coverage: Tier 2 or Tier 3 (preferred or non-preferred brand)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about your medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it happened.